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Abstract. As limb mesenchymal cells differentiate 
into chondrocytes, they initiate the synthesis of type II 
collagen and cease synthesizing type I collagen. 
Changes in the cytoplasmic levels of type I and type II 
collagen mRNAs during the course of limb chondro- 
genesis in vivo and in vitro were examined using 
cloned cDNA probes. A striking increase in cyto- 
plasmic type II collagen mRNA occurs coincident 
with the crucial condensation stage of chondrogenesis 
in vitro, in which prechondrogenic mesenchymal cells 
become closely juxtaposed before depositing a carti- 
lage matrix. Thereafter, a continuous and progressive 
increase in the accumulation of cytoplasmic type II 
coUagen mRNA occurs which parallels the progressive 
accumulation of cartilage matrix by ceils. The onset of 
overt chondrogenesis, however, does not involve acti- 
vation of the transcription of the type II collagen gene. 
Low levels of type II collagen mRNA are present in 
the cytoplasm of prechondrogenic mesenchymal cells 
at the earliest stages of limb development, well before 
the accumulation of detectable levels of type II colla- 
gen. Type I collagen gene expression during chondro- 
genesis is regulated, at least in part, at the translational 
level. Type I collagen mRNAs are present in the cyto- 
plasm of differentiated chondrocytes, which have 
ceased synthesizing detectable amounts of type I colla- 
gen. 
T 
HE onset of cartilage differentiation in the developing 
limb is characterized by a transient cellular condensa- 
tion or aggregation process in which prechondrogenic 
mesenchymal cells become closely juxtaposed to one another 
before initiating cartilage matrix deposition. During this proc- 
ess, a cell-cell interaction, cell shape change, or some other 
event occurs which is necessary to trigger the chondrogenic 
differentiation of the  cells  (15). The  critical  condensation 
process  may be initiated, at least  in part,  by a  progressive 
decrease in the accumulation of extracellular hyaluronate (20, 
35). Fibronectin and type I collagen have been implicated in 
the cell-cell interaction occurring during condensation (7, 21, 
34). Prostaglandin-mediated elevations in cAMP levels during 
condensation are involved in regulating chondrogenesis (3, 6, 
11, 14, 16-18,  32, 33). A change in the shape of  the cells from 
a flattened mesenchymal morphology to a rounded configu- 
ration also plays an important role in the process (2, 41). 
Although considerable insight  has  been  gained into  the 
extracellular influences and intracellular regulatory molecules 
that are involved in regulating limb chondrogenesis, virtually 
nothing is known about the molecular mechanisms by which 
these  factors directly influence the changes in gene activity 
that occur during cartilage  differentiation. Prechondrogenic 
limb mesenchymal cells synthesize type I collagen  (36). As 
the  cells  differentiate into  chondrocytes, they initiate  the 
synthesis of cartilage-characteristic  type II collagen and cease 
synthesizing type  I  collagen  (36). Thus  the  conversion  of 
mesenchymal chondrogenic progenitor cells  into  chondro- 
cytes  involves qualitative  changes  in  the  pattern  of gene 
expression. 
As a first step in studying the molecular regulation of the 
expression of type I and type II collagen genes during chon- 
drogenesis,  we have used cloned cDNA probes  to examine 
changes  in the cytoplasmic levels of type I and II collagen 
mRNAs during chick limb cartilage  differentiation in vitro 
and in vivo.  In particular, we have determined steady-state 
cytoplasmic collagen  mRNA levels during the course of the 
chondrogenic differentiation of the distal subridge mesenchy- 
mat  cells  of stage  25  (12)  chick wing buds  in  micromass 
culture  (10). The  micromass culture  of stage  25  subridge 
mesenchymal cells is a system in which a relatively homoge- 
neous population of  undifferentiated  chondrogenic progenitor 
cells uniformly  progress through the phases of  chondrogenesis 
unencumbered by  the  formation  of the  large  amount  of 
noncartilage tissue that differentiates  in conventional cultures 
derived from the cells of whole limb buds (10). This investi- 
gation thus extends the recent study of Kravis and Upholt 
(22) on developmental changes  in type I1 collagen  mRNA 
levels in whole limb buds and in cultures prepared from whole 
limb  buds.  We  have  found, as expected,  that  the level  of 
cytoplasmic type II collagen  mRNA progressively  increases 
during the course of chondrogenesis.  An unexpected finding 
of considerable interest was the presence of low levels of type 
II collagen mRNA in the cytoplasm of prechondrogenic mes- 
enchymal cells  at  the earliest  stages  of limb development, 
indicating the type II collagen gene is being transcribed well 
before the  onset of overt  cartilage  differentiation and  the 
accumulation of detectable amounts of type II collagen. Fur- 
thermore, our results are consistent with other recent studies 
(1,9, 31) indicating  that type I collagen gene expression during 
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tional  level,  since  substantial  amounts  of type  I  collagen 
mRNAs are present in  the cytoplasm of well-differentiated 
chondrocytes which do not synthesize detectable amounts of 
type I collagen. 
Materials and Methods 
Preparation of Tissue and Cell Culture 
Wing buds were removed from stage 18/19 and stage 25 (12) embryos of White 
Leghorn chicks. Distal wing bud tips (subridge regions) were cut away from the 
stage 25  limb buds as previously described, the size of the excised subridge 
regions being 0.3-0.4 mm from the distal apex of the tissue to the proximal cut 
edge (19).  Ectoderm was removed from the stage  18/19 wing buds and stage 
25  subridge regions, and  micromass cultures were prepared  from  the  distal 
subridge mesenchymal cells of the stage 25 wing buds as previously described 
(10). Purified cartilage rudiments were prepared from the limbs of 7-d embryos 
as described by Linsenmayer (24).  Sterna were dissected from  12-d  embryos 
with special care being taken to remove perichondrial tissue. GH3 cells, a clonal 
line of rat pituitary tumor cells, were supplied by Dr. Bruce White (University 
of Connecticut Health Center). Total RNA purified from 17-d embryonic chick 
calvaria was supplied by Dr. William Upholt (University of Connecticut Health 
Center). 
Hybridization Probes 
Two cloned type 1I collagen cDNA plasmids were used: pCARI  and pCAR2, 
496-base pair (bp) and 680-bp cDNA inserts, respectively, into pBR322 (37). 
The type I collagen eDNA plasmids used were pCg45, a 2,500-bp cDNA insert 
into pBR322 encoding part of the a2(1) collagen subunit (23), and pCALI, a 
675-bp cDNA insert corresponding to al(l) collagen mRNA (38). As a control 
probe  we have  used the cloned  rat growth  hormone cDNA  plasmid, GH I- 
pBR322  (13).  Plasmids pCARI,  pCAR2,  and  pCALI  were supplied by Dr. 
William Upholt;  pCg45 by  Dr.  Helga  Boedtker (Harvard  University, Cam- 
bridge,  MA); and  GHI-pBR322  by  Dr.  F.  Carter Bancroft (Sloan-Kettering 
Institute, New York). Probes were labeled with c~-32P-dCTP (3,000 Ci/mmol; 
Amersham  Corp..  Arlington  Heights,  IL)  by  the  standard  nick translation 
procedure of Maniatis et al. (25) to a  specific activity of 1-2  x  108 cpm/ug. 
The nick-translated probes were separated from unincorporated nucleotide by 
Sephadex G-50 spun-column chromatography (25). 
Hybridization Analyses 
Cytoplasmic mRNA levels were measured in subridge limb mesenchymal cells 
at various times during micromass culture by the cytoplasmic dot hybridization 
procedure of White and Bancroft (40), except that  10 mM vanadylribonucleo- 
side complex was  included during preparation  of cytoplasmic extracts,  and 
aliquots of cell suspensions were  removed  for determination of total  DNA 
content (4).  Cytoplasmic extracts were prepared from  intact limb mesoderm 
and cartilage by homogenizing the tissues in a  Poner-Elvehjem homogenizer 
in ice-cold 10 mM Tris (pH  7),  1 mM EDTA containing 0.5% Nonidet P-40, 
and  10 mM  vanadylribonucleoside complex. The  homogenates were filtered 
through a 20-urn mesh Nitex monofilament screen, and aliquots were removed 
for  DNA determination (4).  The  nuclei were pelleted by centrifugation, and 
the supernatants treated as described (40). 
Aliquots of the cytoplasmic extracts were diluted with  15X SSC (standard 
saline citrate, 0.15  M  NaC1/0.015  M  sodium citrate) and spotted onto nitro- 
cellulose using  the  Schleicher  &  Schuell  micro-sample  filtration  manifold 
(Schleicher &  Schuell,  Inc.,  Keene,  NH).  The  nitrocellulose dot  blots were 
baked at 80°C in a vacuum oven for 90 min, and then prehybridized overnight 
at 420C  in a  solution containing 50%  formamide, 4X  SSC,  50  mM  sodium 
phosphate buffer (pH  6.5),  0.02%  bovine serum albumin, 0.02%  Ficoll 400, 
0.02%  polyvinylpyrrolidone, 0.1% SDS, and  100 ~g/ml of denatured salmon 
sperm DNA. Hybridization was then carried out for 48 h at 55*(? in a solution 
identical to the above except for the addition of 0.1 g/ml ofdextran sulfate and 
1.5  X  10  7 cpm of the appropriate heat-denatured cloned cDNA plasmid. The 
nitrocellulose dot blots were washed four times for 5 min each at 55°C in 2X 
SSC,  0.1% SDS; four times for  15 min each at 55"C in 0.IX SSC,  0.1% SDS; 
and,  exposed to  Kodax  X-Omat  XAR-5  film for various lengths of time at 
-70°C with a  Dupont Cronex lightning plus intensifying screen. The levels of 
hybridizable  RNA  sequences  were  quantified  by  scanning the  dots  of the 
resultant autoradiograms with an  SL-TRFF soft laser scanning densitometer 
(Biomed Instruments Inc., Fullerton, CA), interfaced to an Apple Ile computer 
programmed to  provide automatic peak  integration. Several film exposures 
were scanned to be sure the densities of the dots were in the linear response 
range of the film. 
In one series of experiments, a  slight modification of the dot-blot hydridi- 
zation procedure described by Cheley and Anderson (5) was used to measure 
specific RNA sequences. Briefly, limb tissue was solubilized by sonication in 
7.6  M  guanidine-HCl in  0.1  M  potassium acetate buffer,  pH  5,  and  RNA 
selectively precipitated with ethanol (5).  RNA pellets were dissolved, heated, 
and  aliquots spotted onto  nitrocellulose, as described (5).  Prehybridization, 
hybridization, and washes were as described above. 
Results 
Type H Collagen mRNA during Chondrogenesis 
In our initial studies we examined changes in the cytoplasmic 
levels  of type  II  collagen  mRNA  during the  course of the 
chondrogenic differentiation of the distal subridge mesenchy- 
mal cells of stage 25  wing buds in micromass culture. Stage 
25  subridge mesoderm consists of a  relatively homogeneous 
population of undifferentiated chondrogenic progenitor cells, 
which  uniformly  progress  through  the  phases  of chondro- 
genesis in  micromass culture and  form a  virtually uniform 
sheet of cartilage with little,  if any, non-chondrogenic tissue 
detectable (I 0). In such cultures, widespread prechondrogenic 
aggregations of cells are detected by the end of the first day of 
culture, after which there is a progressive and uniform accu- 
mulation of Alcian blue-positive cartilage matrix by the cells 
(10). 
At 3  h after the initiation of culture, which is well before 
any morphological indications of differentiation by the mes- 
enchymal  cells,  low  but  clearly  detectable  levels  of  RNA 
sequences that hybridize to the cloned type II collagen eDNA 
probes are present in the cytoplasm of the cells (Fig.  l).  By 
20 h, which corresponds to the onset of overt chondrogenesis 
as characterized by the formation of extensive  prechondro- 
genic aggregations of cells throughout the culture, there is a 
greater than  sevenfold increase in  the level  of hybridizable 
type II collagen RNA sequences in the cytoplasm above that 
detectable at 3 h. During the subsequent 3 d of culture, there 
is a continuous and progressive increase in the accumulation 
of cytoplasmic  type  II  collagen  mRNA  which  parallels the 
progressive accumulation of cartilage matrix by the cells. By 
the  fourth day  of culture there  has been  about  a  100-fold 
increase in the amount of cytoplasmic type II collagen mRNA 
per cell  over that  which  was detectable  at  3  h.  A  virtually 
identical pattern of accumulation of cytoplasmic type II col- 
lagen mRNA is observed using either type II collagen eDNA 
plasmid pCAR2 or pCAR1.  No hybridization to the cloned 
rat  growth hormone eDNA  plasmid,  GHl-pBR322  (13),  is 
detectable at any time during the culture period, indicating 
that  none  of the  hybridization detectable  with  the  type  II 
collagen cDNA  probes is due to the nonspecific binding of 
plasmid DNA sequences. 
The presence of low but clearly detectable levels of RNA 
sequences complementary to cloned type II eDNA probes at 
3  h  after the initiation  of culture suggested that the type It 
collagen gene is being expressed at low levels before the onset 
of overt differentiation.  We  have obtained further evidence 
for this by demonstrating that hybridizable type II collagen 
RNA sequences are present in the cytoplasm of the prechon- 
drogenic mesenchymal cells in the distal subridge region of 
the stage 25 wind bud (Fig.  2). It should be emphasized that 
the distal subridge region at stage 25 consists of a homogene- 
ous-appearing population of cytologically unspecialized mes- 
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Figure 1. (A) Autoradiograph demonstrating the hybridization of32P- 
labeled type II collagen cDNA plasmid, pCAR2, to RNA sequences 
in the cytoplasm of subridge limb mesenchymal cells at various times 
during the course of their chondrogenic differentiation in micromass 
culture.  The 10-ul aliquots correspond  to cytoplasmic extracts from 
the equivalent  of 2.3 x  105 cells at 3 h up to 7.2 x  l0  s cells at 96 h. 
(B) The levels of type II collagen mRNA at each period of culture 
were determined  by scanning densitometry  as described in Materials 
and Methods. The amount of cytoplasmic type II collagen mRNA at 
each time point is presented as an amount relative to that at 96 h of 
culture, which was arbitrarily set to 1,000. Values are means of 2 (3 
h) or 3 (24-96 h) determinations  _+ SEM. 
enchymal cells (19,  30).  The  cells  synthesize  high  levels of 
hyaluronate (20) and type I  collagen, but do not synthesize 
detectable amounts of type II collagen (28, 29). The amount 
of cytoplasmic type II collagen mRNA in these prechondro- 
genic mesenchymal cells is 0.5-1.5% of the amount we detect 
in the cytoplasm of the chondrocytes of 7-d limb cartilage or 
12-d sternal cartilage. 
In an attempt to determine how early in limb development 
the  type  II  collagen  gene  is  expressed,  we  looked  for  the 
presence of hybridizable type II collagen RNA in cytoplasmic 
extracts prepared from "the mesenchymal cells comprising the 
wing buds of stage  18/19 embryos, which is shortly after the 
initial  formation of the limb bud. As shown in Fig. 2, RNA 
Figure 2. (A) Hybridization of type II collagen cDNA to cytoplasmic 
extracts of mesenchymal cells from stage 18/19 wing buds (18); two 
separate preparations of stage 25 subridge mesenchymal cells (25-I 
and 25-2); and, two separate preparations of rat pituitary GH3 cells 
(GH-1 and GH-2), as determined by cytoplasmic dot hybridization 
(reference 40). In each case, hybridization is to cytoplasmic extracts 
from 6.8 ×  105 cell equivalents. (B) Hybridization of type II collagen 
cDNA to RNA purified from stage  18/19 mesenchymal cells (18), 
stage 25  subridge mesenchymal cells (25), and GH3 cells (GH) as 
determined by dot-blot hybridization (reference 5).  Hybridizations 
are to RNA from 7.2 x  10  s cell equivalents. 
Table I.  The Amount of Type H Collagen mRNA in the 
Prechondrogenic Mesenchymal Cells of Stage 18/19 Wing 
Buds and the Distal Subridge Mesenchymal  Cells of Stage 
25 Wing Buds as Determined by Either Cytoplasmic Dot 
Hybridization  (Cyto-dot) or Dot-blot Hybridization  of 
Purified RNA 
mRNA/~g DNA 
Mesenchymal cells  Cyto-dot  Dot-blot 
Stage 18/19 wing buds  20.7  15.0 
Stage 25 subridge region  10  10.9 
The levels of mRNA were quantified by scanning densitometry. The amount 
of mRNAfizg DNA is expressed as an amount relative to that in stage 25 
subridge mesenchymal cells as determined by cytoplasmic dot hybridization, 
which was arbitrarily set to 10. 
sequences  complementary  to  the  type  II  collagen  cDNA 
probes are clearly detectable in the cytoplasm of prechondro- 
genic  limb  mesenchymal  cells  even  at  this  early  stage  of 
development.  In  fact,  the  amount  of hybridizable  type  II 
collagen mRNA per cell is consistently somewhat greater (1.5- 
2  times) in stage  18/19  mesenchymal cells than  in stage 25 
subridge  mesenchymal  cells  (Table  I).  In contrast,  there  is 
virtually  no  detectable  hybridization  of the  type  II cDNA 
probes  to  cytoplasmic  extracts  of a  clonal  cell  line  of rat 
pituitary GH3 cells (Fig. 2), which served as a negative control. 
To  confirm  the  results  obtained  using  cytoplasmic  dot 
hybridization, we purified RNA from stage  18/19 limb mes- 
enchymal  cells,  stage  25  subridge  mesenchymal  cells,  and 
GH3 cells using the guanidine-HCl extraction/ethanol precip- 
itation procedure of Cheley and Anderson (5),  and analyzed 
the RNA by dot-blot hybridization. Type II collagen mRNA 
sequences are clearly detectable in the RNA isolated from the 
prechondrogenic  limb  mesenchymal  cells  at  either  stage, 
whereas no hybridization is detectable to RNA extracted from 
GH3 ceils (Fig. 2). The quantitative results we obtained using 
cytoplasmic dot  hydridization  or dot-blot  hybridization  of 
purified RNA are quite comparable (Table I). 
Since prechondrogenic limb mesenchymal cells synthesize 
type I collagen and the sequence homology between types I 
and II collagens is quite high, it was crucial to eliminate the 
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with type II collagen cDNA in these  cells  might be  due to 
cross-hybridization  of the  type  II  cDNA  probe  to  type  I 
collagen mRNA sequences.  In this regard, it should be em- 
phasized that our hybridizations and washes were performed 
under very stringent conditions, i.e. hybridizations being done 
in 50% formamide at 55"C, and multiple washes being done 
in  0.1X  SSC  at  55"C.  These  conditions  are,  in  general,  as 
stringent as those that several investigators have shown pre- 
vent  cross-hybridization  between  several  type  II  collagen 
cDNAs and type I collagen mRNAs, or between type I colla- 
gen cDNAs and type II collagen mRNAs (8,  9, 26,  37).  To 
directly test the possibility of cross-hybridization, aliquots of 
cytoplasmic  extracts  of stage  18/19  and  stage  25  subridge 
mesenchymal  cells  and  aliquots  of purified  calvaria  RNA, 
which  contains  large  quantities  of  both  al(I)  and  a2(I) 
mRNAs,  were  hybridized  with  the  type  II collagen  cDNA 
probe.  In  parallel  experiments,  equivalent  aliquots  of the 
cytoplasmic extracts and calvaria RNA were hybridized with 
either al(I) or a2(I) cDNA probes. As shown in Fig. 3, under 
conditions in which type II cDNA hybridizes to cytoplasmic 
RNA sequences in limb  mesenchymal cells,  there is no de- 
tectable hybridization of the type II probe to an amount of 
calvaria  RNA which contains 4-5  times  more  hybridizable 
al(I) and  a2(I)  mRNA sequences than  do cytoplasmic ex- 
tracts of limb mesenchymal cells.  This demonstrates that the 
hybridization  of the  type  II cDNA  probe  to  sequences  in 
prechondrogenic mesenchymal cells is  not due to cross-hy- 
bridization of the probe to al(I) or a2(I) mRNA sequences, 
or to other RNA species present in total calvaria RNA. 
Type I  Collagen mRNA during Chondrogenesis 
Changes in the  cytoplasmic levels of mRNAs for the  al(I) 
and a2(I) chains of type I collagen during the chondrogenic 
differentiation  of stage  25  subridge  mesenchymal  cells  in 
micromass culture are summarized in Table II. There is not 
a  progressive decline in the accumulation of type I collagen 
mRNAs during the course of chondrogenesis as we had antic- 
Figure  3.  (A) Autoradiographs comparing hybridization of type  II 
collagen cDNA (al[ll]) and a2(I) cDNA to cytoplasmic aliquots of 
stage 18/19 mesenchymal cells (18) (3.4 ×  105 cell equivalents), stage 
25 subridge mesenchymal cells (25)  (6.8 x  105 cell equivalents), and 
to 0.8 ug (CV-1) and 0.4 ug (CV-2) of calvaria RNA. (B) Hybridi- 
zation  of type II collagen cDNA (al[ll]) and al(l) cDNA to cyto- 
plasmic aliquots of stage 18/19 (18) (3.2 x  l0  s cell equivalents) and 
stage 25 subridge (25) (6.4 ×  l0  s cell equivalents) mesenchymal cells 
and to 0.4 ug (CV-1) and 0.1 #g (CV-2) of calvaria RNA. 
Table II. Cytoplasmic Type I Collagen mRNA Accumulation 
during the Course of the Chondrogenic Differentiation of 
Subridge Limb Mesenchymal  Cells in Micromass Culture 
mRNA/~tg DNA 
Hours in culture  a2(1)  al(l) 
3  745  582  290 
20  349  324  200 
48  417  742  525 
72  783  613  578 
96  1,000  1,000  1,000 
The  levels of mRNA  were  quantified  by  scanning  densitometry.  In  each 
experiment, the amount of mRNA/ug DNA at each timepoint  is expressed as 
an amount relative to that at 96 h of culture, which was arbitrarily set at 1,000. 
Note that the  normalized  a2 (I) and  al (I) mRNA levels cannot be directly 
compared, 
Figure 4. (A) Hybridization  of a2(1) cDNA to cytoplasmic aliquots 
of stage 25 subridge mesenchymal cells (M1 and 3/12 which represent 
1.3 and 0.65 ×  l0  s cell equivalents, respectively) and differentiated 
chondrocytes of 7-d limb cartilage (LC) (0.4 ×  105 cell equivalents) 
and  12-d sternal  cartilage (SC) (0.8  ×  105 cell equivalents).  (B) 
Hybridization of a 1  (I) cDNA to cytoplasmic aliquots of stage 18/19 
mesenchymal cells (M1) (2 x  105 cell equivalents), stage 25 subridge 
mesenchymal cells (M2) (3 x  105 cell equivalents), and differentiated 
chondrocytes of 7-d limb (LC) (2 ×  105 cell equivalents) and  12-d 
sternal cartilage (SC) (1 x  l0  s cell equivalents). 
ipated. Rather, the relatively high levels of cytoplasmic type I 
collagen  mRNAs  present  during  the  early  culture  period 
persist, and, in fact, there is an increase in the level of type I 
mRNAs during the course of in vitro cartilage differentiation 
(Table II). This was unexpected, since at the end of  the culture 
period few, if any, nonchondrogenic cells are detectable, and 
little  type  I  collagen  production  would  be  expected  to  be 
occurring. It is conceivable, however, that some type I colla- 
gen-producing fibrogenic cells differentiated  in the cultures 
even though such cells are not readily detectable morpholog- 
ically. 
We,  therefore,  examined  the  levels  of  type  I  collagen 
mRNAs in  the  purified  chondrocytes comprising 7-d  limb 
cartilage and  12-d sternal  cartilage,  since these cartilages do 
not synthesize immunologically or biochemically detectable 
amounts of type I collagen (36). As shown in Fig. 4 and Table 
III, substantial levels of a 1  (I) and a2(I) mRNA sequences are 
present in the cytoplasm of the differentiated chondrocytes of 
both limb and sternal cartilage. The levels of al(I) and a2(I) 
mRNAs per cell in limb and sternal cartilage are comparable 
to  the  levels  found in  prechondrogenic  limb  mesenchymal 
cells which do synthesize type I collagen (Table III). 
By comparing the relative hybridization of the a l(I) cDNA 
probe and the a2(I) cDNA probe to equal amounts of  purified 
calvaria RNA and to equal cytoplasmic aliquots of limb and 
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Cytoplasm of  Differentiated Limb and Sternal Chondrocytes 
Compared to Prechondrogenic Mesenchymal Cells 
mRNA/#g DNA 
7-d limb 
mRNA  Limb mesenchyme  cartilage  12-<t sternal cartilage 
a2 (I)  10  12.9  4.7 
al  (I)  10  14.3  10.4 
The prechondrogenic mesenchymal cells are those comprising the distal sub- 
ridge  region of stage 25 wing buds. The levels of mRNA were determined by 
scanning densitometry. The amounts of a2 (1) or a111) mRNA/ug DNA in the 
chondrocyles is expressed as an amount relative  to lhal in the mesenchymal 
ce~ts, which was arbitrarily set to 10. Note that the normalized ¢r2 (I) and a I (I) 
mRNA levels cannot be directly compared. 
sternal chondrocytes, the ratio of a l(I) and a2(I) mRNAs in 
the cytoplasm of the chondrocytes can be estimated, since it 
is known that the al(l)/a2(I) mRNA ratio in calvaria is 2:1 
(39).  The cytoplasmic al(I)/a2(I) mRNA ratio in limb and 
sternal cartilage is about 0.4 and 0.75, respectively. Thus in 
differentiated chondrocytes which do not synthesize type I 
collagen, there is a large excess of cytoplasmic a2(I) mRNAs 
relative to c~ 1(I) mRNAs, which contrasts to the a l(I)/a2(I) 
mRNA ratio of 2:1 in calvaria, Interestingly, the cytoplasmic 
al(l)/u2 (I) mRNA ratio is also not 2:1  in prechondrogenic 
limb mesenchymal cells. In stage  I8/I9 limb mesenchymal 
ceils  the al(I)/a2(I)  mRNA  ratio  is -l:l,  and  in  stage  25 
subridge mesenchymal cells the ratio is 1:3. 
Discussion 
Our studies on the accumulation of cytoplasmic type II col- 
lagen mRNA during the progression of limb cartilage differ- 
entiation in vivo and in vitro have revealed several interesting 
aspects of the regulation of collagen gene activity during the 
process,  First  of all,  a  striking  increase  in  the  amount  of 
cytoplasmic type II collagen mRNA is delectable coincident 
with the crucial condensation or aggregation phase of chon- 
drogenesis in vitro, in which prechondrogenic mesenchymal 
cells become closely juxtaposed to one another before depos- 
iting a  cartilage matrix.  This temporal correlation suggests 
that this change in type II collagen gene activity occurs as a 
consequence  of regulatory  events  taking  place  during  the 
condensation process. Among those interrelated events that 
have  previously been  shown  to  be  involved  in  triggering 
chondrogenesis during condensation are cell-cell and/or cell- 
matrix interactions; cytoskeletal-linked change in cell shape; 
and prostaglandin-mediated elevations in cellular cAMP lev- 
els (see the introduction). 
After the crucial condensation process, there is a continuous 
and progressive increase in the accumulation of cytoplasmic 
type lI collagen mRNA which parallels the progressive  accu- 
mulation of cartilage matrix by the cells. This observation is 
in agreement with the recent study of Kravis and Upholt (22) 
on type II collagen mRNA levels in whole limb buds and in 
high density cultures prepared from whole limb buds. These 
results indicate that the expression of  the type II collagen gene 
during limb cartilage differentiation is regulated primarily by 
mechanisms controlling the rate of accumulation of type II 
collagen  mRNA.  It  is  quite  likely that  greatly accelerated 
transcription of the type II collagen gene is largely responsible 
for this increase in mRNA accumulation, although acceler- 
ated processing of nuclear transcripts and/or an increase in 
cytoplasmic mRNA  stability might also  conceivably be in- 
volved. 
It is  important to emphasize, however, that the onset of 
overt cartilage differentiation apparently does not involve the 
initiation  or  activation of the  transcription  of the  type II 
collagen gone.  We unexpectedly found low, but clearly de- 
tectable levels of type II collagen mRNA in the cytoplasm of 
the prechondrogenic mesenchymal cells comprising stage  18/ 
19 wing buds and the distal subridge region of stage 25 wing 
buds. Low levels of type II mRNA have also been detected in 
stage  20 limb buds (22).  Thus the type II  collagen gone  is 
being expressed at low levels in limb mesenchymal cells at 
the earliest stages of limb development, well before the onset 
of overt  cartilage  differentiation and  the  accumulation  of 
detectable amounts of type II collagen. It is possible that type 
II collagen mRNAs are being translated in prechondrogenic 
mesenchymal cells, but that the amount of type II collagen 
that accumulates is below the level of detection of the im- 
munological and biochemical procedures that have been used 
to study its production. In this regard, at least a portion of 
the type II collagen mRNA in stage 20 limb buds is associated 
with polysomes (22). Alternately, it is possible that posttran- 
scriptional regulatory controls may limit the  translation of 
type II collagen mRNA before the overt differentiation of the 
cells.  In  any event, the low level  expression of the type II 
collagen  gene by chondrogenic progenitor ceils  before the 
onset of overt differentiation may represent a molecular man- 
ifestation  of the  state  of determination  of the  cells.  It  is 
conceivable that the presence of cytoplasmic type II collagen 
mRNA might be useful as a  molecular marker to elucidate 
when and where during embryogenesis determination of a 
specific  limb cell type occurs. The precocious expression of 
muscle-specific actin genes has served as a molecular marker 
for detecting the onset of muscle cell determination in  the 
amphibian embryo (27). 
Our results indicate that type I collagen gene expression 
during chondrogenesis is  regulated, at  least  in  part, at  the 
translational  level.  Substantial amounts of mRNAs  for the 
al(I) and a2(I) chains of type I collagen are present in the 
cytoplasm of the well-differentiated chondrocytes comprising 
7<I limb cartilage and  12<1 sternal cartilage,  which do not 
synthesize detectable amounts of type I collagen.  The levels 
of cytoplasmic type  I  collagen  mRNAs  per  cell  in  these 
cartilage tissues is comparable to the levels found in prechon- 
drogenic mesenchymal cells.  Although it is difficult to un- 
equivocally eliminate the possibility,  it is highly unlikely that 
a  small  number of potentially contaminating perichondrial 
cells could account for the substantial levels of type I mRNAs 
in our cartilage preparations. Evidence for the translational 
regulation of type I collagen gene expression in chondrocytes 
has also  recently been provided by other investigators.  Type 
I collagen mRNAs have been detected in limb and sternal 
cartilage (22); in the cytoplasm of cultured sternal chondro- 
cytes (31); and in cultured vertebral chondrocytes, which also 
do not synthesize type I collagen (1, 9). 
We  have also found that  in  differentiated chondrocytes, 
which are not producing type I collagen,  there is an excess of 
a2(I) mRNAs  relative to al(I) mRNAs in  cytoplasm. This 
contrasts to the a l(I)/a2(I) mRNA ratio of 2:1 in embryonic 
chick calvaria that are synthesizing large quantities of type I 
Kosher et al. Collagen Gene Expression during Chondrogenesis  1155 collagen (39). Our finding is consistent with the recent obser- 
vation of Saxe et al. (31) that cultured sternal chondrocytes 
contain  substantial quantities  a2(I)  mRNAs  in  their cyto- 
plasm,  but only small quantities of al(I)  mRNAs.  Interest- 
ingly,  our results  indicate that the cytoplasmic  a l(I)/a2(I) 
mRNA ratio is also not 2:1 in prechondrogenic mesenchymal 
cells,  the  al(l)/a2(I)  ratio being  ~1:1  in  stage  18/19  limb 
mesenchymal cells and ~1:3 in stage 25 subridge  mesenchy- 
mal cells.  It will be important to determine if the decrease  in 
the c¢l(I)/a2(I) mRNA  ratio in stage 25 subridge cells com- 
pared  to stage  18/19 limb mesenchymal cells reflects  differ- 
ences  in  the  rate  of type  I  collagen  production  in  these 
progenitor cells. 
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